10 things you need to know before you buy into the MYOB Group Ltd IPO

Game on: MYOB Group Ltd will list on the ASX in May, ramping up its competition with arch rival XERO FPO NZ (ASX:XRO). Should you partake in the biggest IPO since Medibank Private Ltd (ASX:MPL)?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Last week, MYOB Group Ltd released the prospectus for its initial public offering (IPO) in what is bound to be one of the biggest public floats of the year. The accounting software provider will seek to raise up to $833.8 million from retail and institutional investors in what could give the company a market capitalisation of $2.26 billion.

Before you buy into the IPO however, you should consider these 10 important facts:

  1. Price. As was the case during Medibank Private Ltd's (ASX: MPL) float last year, investors have no idea how much they will end up paying for each MYOB share. The company has set an indicative price range of $3 to $4 while an exact dollar figure won't be known until 1 May.
  2. Market Capitalisation. A total of $831.7 – $833.8 million will be raised during the float, giving the company a market capitalisation of $1.9 – $2.26 billion. Its enterprise value will be $2.34 – $2.69 billion.
  3. Value. Depending on the price at which the shares sell for, MYOB will trade at 20.9 to 24.9 times net profit after tax and amortisation (NPATA).
  4. Dividends: MYOB provided an implied dividend yield forecast of 2.8% to 3.3% for the 12 months ended 30 June 2016, with the intention to payout around 60% to 80% of overall earnings. While that is certainly nothing to scoff at, there are other stocks offering far greater dividends for income investors.
  5. First Test. As reported by the Fairfax press, MYOB's retail brokers JBWere, UBS Wealth Management and Bell Potter have been told to bid for the shares by Thursday April 9. That will provide a good indication of the level of demand for the $830 million float, which could also provide a better estimate for the price at which the shares will list on the ASX.
  6. Customers. MYOB claims to have 1.2 million customers. Of these, 116,000 are paying users of its cloud products and 389,000 are paying users of its desktop products. The other 716,000 are non-paying users of its desktop products (many of which MYOB believes will continue to migrate towards its cloud-based services).
  7. Risks. One of the biggest risks facing MYOB is if it is unable to increase average revenue per customer. To do that, more and more non-paying users will need to switch to cloud solutions while MYOB will also need to pass on price increases and introduce new services. Competition could certainly impact its ability to achieve this (more on that below).
  8. Rivalry. MYOB has grown strongly under the control of Bain Capital, but its ability to continue growing could be seriously hindered by competitors Reckon Limited (ASX: RKN) and, in particular, XERO FPO NZ (ASX: XRO). Xero is a pure cloud-accounting software provider and is quickly gaining market share in Australia, New Zealand the UK and the US. MYOB is more focused on the Australasian markets.
  9. Popularity. It is clear that XERO is becoming increasingly popular on a global scale with its Google search term popularity having surged past that of MYOB. That is a concern for MYOB, which has come under fire from Xero's CEO Rod Drury for not disclosing the appropriate information in its prospectus.
  10. Patience. Investors also need to remember that demand can be high for a company's stock during and immediately after its IPO, but can then cool in the weeks or months that follow. While that certainly isn't the case for all IPOs (queue Medibank Private), investors who wait a while could be presented with a more attractive price to purchase MYOB shares.
Motley Fool contributor Ryan Newman owns shares in XERO. The Motley Fool owns shares in XERO. You can follow Ryan on Twitter @ASXvalueinvest. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policyThis article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »